Loading clinical trials...
Loading clinical trials...
Application of Targeting Transcranial Direct Current Stimulation (tDCS) Stimulation in the Treatment of Refractory Status Epilepticus
The purpose of the study is to assess the efficacy and safety of targeting tDCS stimulation for treatment of Refractory status epilepticus
After being informed about the study and potential risks, the recruited patients, giving written informed consent, will be determined of the eligibility for study entry. The patients who meet the eligibility requirements will be randomized in a 1:1 ratio to undergo targeting tDCS stimulation (up to 10 times) or sham stimulation.
Age
14 - 80 years
Sex
ALL
Healthy Volunteers
No
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Start Date
April 1, 2024
Primary Completion Date
December 31, 2024
Completion Date
March 31, 2025
Last Updated
July 31, 2024
32
ESTIMATED participants
tDCS stimulation
DEVICE
TDCS sham-stimulation
DEVICE
research centre of Xuanwu hospital Capital Medical University
CONTACT
+8601083198899liugangqingyi@sina.comLead Sponsor
Xuanwu Hospital, Beijing
NCT07383779
NCT07281027
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions